Desmopressin Acetate



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Insipidus 30.1%
Enuresis 15.4%
Product Used For Unknown Indication 8.9%
Hypopituitarism 7.2%
Hypertension 4.8%
Nocturia 4.8%
Von Willebrand's Disease 4.1%
Depression 2.7%
Drug Use For Unknown Indication 2.7%
Diabetes Mellitus 2.4%
Vitamin Supplementation 2.4%
Type 2 Diabetes Mellitus 2.1%
Benign Prostatic Hyperplasia 1.7%
Bladder Disorder 1.7%
Congestive Cardiomyopathy 1.7%
Dental Implantation 1.7%
Bleeding Time Prolonged 1.4%
Central Diabetes Insipidus 1.4%
Coronary Artery Disease 1.4%
Dry Mouth 1.4%
Drug Ineffective 17.6%
Hyponatraemia 11.8%
Water Intoxication 10.1%
Thirst 5.9%
Urine Output Increased 5.9%
Vomiting 5.0%
Overdose 4.2%
Pharmaceutical Product Complaint 4.2%
Drug Effect Decreased 3.4%
Headache 3.4%
Inappropriate Antidiuretic Hormone Secretion 3.4%
Rash 3.4%
Vena Cava Thrombosis 3.4%
Weight Increased 3.4%
Blood Sodium Decreased 2.5%
Brain Oedema 2.5%
Convulsion 2.5%
Nausea 2.5%
Pollakiuria 2.5%
Pulmonary Embolism 2.5%
Secondary
Diabetes Insipidus 13.1%
Obsessive-compulsive Disorder 9.7%
Enuresis 9.2%
Hypertension 6.3%
Product Used For Unknown Indication 6.3%
Hypopituitarism 5.8%
Diabetes Mellitus 4.9%
Drug Use For Unknown Indication 4.9%
Benign Prostatic Hyperplasia 4.4%
Von Willebrand's Disease 4.4%
Depression 3.9%
Hormone Replacement Therapy 3.9%
Ill-defined Disorder 3.4%
Central Diabetes Insipidus 2.9%
Convulsion 2.9%
Coronary Artery Disease 2.9%
Hypertonic Bladder 2.9%
Lung Adenocarcinoma 2.9%
Nocturia 2.9%
Dental Implantation 2.4%
Hyponatraemia 14.3%
Water Intoxication 14.3%
Urine Output Increased 9.1%
Drug Ineffective 7.8%
Vomiting 7.8%
Headache 5.2%
Hypouricaemia 3.9%
Nausea 3.9%
Urine Output Decreased 3.9%
Wrong Drug Administered 3.9%
Basophil Count Increased 2.6%
Drug Hypersensitivity 2.6%
Facial Paresis 2.6%
Hypochloraemia 2.6%
Incontinence 2.6%
Intracardiac Thrombus 2.6%
Jaundice 2.6%
Pain 2.6%
Pulmonary Embolism 2.6%
Pulseless Electrical Activity 2.6%
Concomitant
Product Used For Unknown Indication 30.8%
Drug Use For Unknown Indication 27.3%
Hypopituitarism 7.9%
Growth Hormone Deficiency 5.5%
Diabetes Insipidus 3.5%
Osteoporosis 2.6%
Hypertension 2.0%
Hypothyroidism 2.0%
Blood Antidiuretic Hormone Decreased 1.8%
Ill-defined Disorder 1.7%
Bladder Disorder 1.6%
Adrenal Insufficiency 1.5%
Prophylaxis 1.5%
Blood Follicle Stimulating Hormone Decreased 1.5%
Blood Luteinising Hormone Decreased 1.5%
Constipation 1.5%
Depression 1.5%
Hypogonadism 1.5%
Blood Corticotrophin Decreased 1.4%
Rheumatoid Arthritis 1.4%
Vomiting 16.0%
Neoplasm Recurrence 12.3%
Craniopharyngioma 6.1%
Death 5.5%
Muscle Spasms 4.9%
Progressive Multifocal Leukoencephalopathy 4.9%
Sepsis 4.9%
Weight Decreased 4.9%
Hypernatraemia 4.3%
Renal Failure 4.3%
Pituitary Tumour Benign 3.7%
Somnolence 3.7%
White Blood Cell Count Increased 3.7%
Epiphysiolysis 3.1%
Infection 3.1%
Malignant Melanoma 3.1%
Renal Failure Acute 3.1%
Urinary Tract Infection 3.1%
Weight Increased 3.1%
Arthropathy 2.5%
Interacting
Hypothalamo-pituitary Disorder 15.8%
Analgesic Therapy 10.5%
Depression 10.5%
Enuresis 10.5%
Hypercholesterolaemia 10.5%
Brain Neoplasm 5.3%
Convulsion 5.3%
Diabetes Insipidus 5.3%
Drug Use For Unknown Indication 5.3%
Epilepsy 5.3%
Gastritis Prophylaxis 5.3%
Hypopituitarism 5.3%
Migraine 5.3%
Hyponatraemia 33.3%
Depressed Level Of Consciousness 16.7%
Loss Of Consciousness 16.7%
Vomiting 16.7%
Water Intoxication 16.7%